Compass Pathways PLC (FRA:5Y6)
€ 4.26 0 (0%) Market Cap: 291.47 Mil Enterprise Value: 126.62 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 38/100

Compass Pathways PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 02:15PM GMT
Release Date Price: €29.2 (+3.18%)
Cailin Mcgurk

Good morning, good afternoon, everybody. My name is Cailin Mcgurk. I'm a Managing Director in the Global Health Care team at Morgan Stanley. It gives me great pleasure today to welcome George Goldsmith, Chairman, Co-Founder and CEO of COMPASS Pathways.

Before we get started, if you'll just bear with me, I might need to read a very brief disclaimer. So for important disclosures, could you please refer to the Morgan Stanley research disclosure website at www.morganstanley.com/research disclosures. And if you have any other questions, please refer those to your Morgan Stanley sales representative.

And with that, George, welcome. Great to have you at our conference. I can say after the last 18 months, which has been incredibly tolling in terms of mental health for all of us around the world, it's great to have COMPASS.

Questions & Answers

Cailin Mcgurk

Maybe 1 thing that I thought would be really sort of interesting to start with is, I know that you've been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot